3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Nasopharyngeal Carcinoma
35
Esophageal Squamous Cell Carcinoma
19
Carcinoma, Non-Small-Cell Lung
19
Carcinoma, Hepatocellular
18
Squamous Cell Carcinoma of Head and Neck
15
Triple Negative Breast Neoplasms
14
Breast Neoplasms
12
Uterine Cervical Neoplasms
11
Colorectal Neoplasms
11
Small Cell Lung Carcinoma
10
Melanoma
10
Carcinoma, Renal Cell
9
Stomach Neoplasms
8
Recurrence
8
Head and Neck Neoplasms
7
Rectal Neoplasms
5
Neoplasm Metastasis
5
Esophageal Neoplasms
5
Carcinoma, Transitional Cell
5
Advanced Solid Tumor
5
Urinary Bladder Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Neoplasms
4
Liver Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Cholangiocarcinoma
4
Solid Tumor
3
Nasopharyngeal Neoplasms
3
Interventions
Methotrexate
6
Dactinomycin
5
camrelizumab
3
Flow Cytometry
3
Drug Therapy
3
toripalimab
2
pembrolizumab
2
apatinib
2
Vacuum Curettage
2
Psychiatric Rehabilitation
2
Methylprednisolone
2
Leucovorin
2
Immunologic Techniques
2
Cyclophosphamide
2
Alemtuzumab
2
zimberelimab
1
dostarlimab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Vincristine
1
Tacrolimus
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Prednisone
1
Paclitaxel
1
Moxifloxacin
1
Microarray Analysis
1
Methods
1
Interleukin-12 Subunit p35
1
Interleukin-11
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Gestational Trophoblastic Disease
×
toripalimab
×
Clear all
NCT06028672
2025-02-06
TA56
Peking Union Medical College Hospital
Phase NA
Recruiting
40 enrolled
NCT06020755
2024-12-31
TA7
Peking Union Medical College Hospital
Phase 2
Recruiting
17 enrolled